CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 4.20p |
Change Today | -0.050p |
% Change | -1.18 % |
52 Week High | 7.20 |
52 Week Low | 2.90 |
Volume | 411,078 |
Shares Issued | 95.95m |
Market Cap | £4.03m |
Beta | 0.51 |
RiskGrade | 464 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:08 | 6,835 @ 4.10p |
14:54 | 75,000 @ 4.11p |
12:57 | 22 @ 4.40p |
12:56 | 559 @ 4.11p |
11:42 | 11,271 @ 4.33p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research